Seasonal Influenza Vaccine Market Set to Grow in Near Future

The vaccine market is booming globally. With the consequent changes in the approach of population, which is focused on preventive healthcare rather than the curative healthcare, the demand for vaccines has increased all over the world. Further, our research reveals that the demand in influenza vaccine market is highly variable and limited numbers of players are there that are able to cope with the annual updates requirement and expensive manufacturing process. However, threats of pandemic influenza and growing public awareness regarding influenza have increased the demand for influenza vaccines across the world.

 

Our study reveals that the seasonal influenza vaccine market growth depends on various factors such as, influenza, season severity, weather, disease duration, media coverage, and availability of the vaccine. According to our research report “Global Vaccine Market Forecast to 2012”, backed by these factors, the market of seasonal influenza vaccines is projected to grow at a CAGR of around 11% during 2009-2012. Our research study discusses all the other factors that are driving the seasonal influenza vaccines market. It has also analyzed other adult/travel and therapeutic vaccines including influenza.

 

Our analysis of the global vaccine market with emphasis on the country level illustrates that fast developing countries such as, India and China will raise their overall share. Currently, these countries have been actively participating in market activities and vaccine manufacturers are booking profits on their sales. Besides, other countries will facilitate the development of vaccine market in their respective places to minimize health problems.

 

Our report is an outcome of extensive research and objective analysis of the vaccine market in key countries of the world. It identifies all the necessary factors and aspects related to the market and represents current industry status along with future forecast on vaccine types and countries for the period 2009-2012. In addition, the description of key players and their recent activities have been provided to showcase an effective and balanced outlook of the global vaccine market.

For more information visit: http://www.rncos.com/Report/IM153.htm